Abstract
In spite of the improvements in transfusion safety occurred in the last decades, platelet septic transfusions still represent a cause for concern. Microbial screening of blood products cannot ensure transfusion sterility, so that pathogen inactivation methods and a timely management of infectious events actually play the most relevant role. Biofilm production has been associated to several human illnesses; also, it promotes bacterial adherence to platelet bags and colonization of recipients catheter after transfusion. Therefore, facing biofilm communities is required to reduce the contamination risk and the occurrence of post-infusion events. In this context, the use of tigecycline as a wide-spectrum antibiofilm drug is discussed, along with recent patents about biofilm treatment by quorum-sensing blockers, bacteriophage-based therapy and antibiofilm oral compounds.
Keywords: Transfusion, platelet, biofilm, bacteremia, sepsis, septicaemia, tigecycline, glycylglycine
Recent Patents on Anti-Infective Drug Discovery
Title: Bacterial Contamination of Platelets and Septic Transfusions: Review of the Literature and Discussion on Recent Patents About Biofilm Treatment
Volume: 5 Issue: 2
Author(s): Vincenzo Savini, Chiara Catavitello, Daniela Astolfi, Andrea Balbinot, Gioviana Masciarelli, Arianna Pompilio, Anna M. Quaglietta, Patrizia Accorsi, Giovanni Di Bonaventura, Claudio D'Amario, Domenico D'Antonio and Antonio Iacone
Affiliation:
Keywords: Transfusion, platelet, biofilm, bacteremia, sepsis, septicaemia, tigecycline, glycylglycine
Abstract: In spite of the improvements in transfusion safety occurred in the last decades, platelet septic transfusions still represent a cause for concern. Microbial screening of blood products cannot ensure transfusion sterility, so that pathogen inactivation methods and a timely management of infectious events actually play the most relevant role. Biofilm production has been associated to several human illnesses; also, it promotes bacterial adherence to platelet bags and colonization of recipients catheter after transfusion. Therefore, facing biofilm communities is required to reduce the contamination risk and the occurrence of post-infusion events. In this context, the use of tigecycline as a wide-spectrum antibiofilm drug is discussed, along with recent patents about biofilm treatment by quorum-sensing blockers, bacteriophage-based therapy and antibiofilm oral compounds.
Export Options
About this article
Cite this article as:
Savini Vincenzo, Catavitello Chiara, Astolfi Daniela, Balbinot Andrea, Masciarelli Gioviana, Pompilio Arianna, M. Quaglietta Anna, Accorsi Patrizia, Di Bonaventura Giovanni, D'Amario Claudio, D'Antonio Domenico and Iacone Antonio, Bacterial Contamination of Platelets and Septic Transfusions: Review of the Literature and Discussion on Recent Patents About Biofilm Treatment, Recent Patents on Anti-Infective Drug Discovery 2010; 5 (2) . https://dx.doi.org/10.2174/157489110791233531
DOI https://dx.doi.org/10.2174/157489110791233531 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
COVID-19: Are Experimental Drugs a Cure or Cause?
Current Drug Safety Cyclooxygenase-2 Biology
Current Pharmaceutical Design Modulation of Collagen Turnover in Cardiovascular Disease
Current Pharmaceutical Design Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Towards A Superior Streptokinase for Fibrinolytic Therapy of Vascular Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Nicotine and Gastrointestinal Disorders: Its Role in Ulceration and Cancer Development
Current Pharmaceutical Design Total Polyphenols and Bioactivity of Seeds and Sprouts in Several Legumes
Current Pharmaceutical Design Adverse Drug Reactions and Safety Considerations of NSAIDs: Clinical Analysis
Current Drug Safety Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Recent Advances in the Synthesis of Antischistosomal Drugs and Agents
Mini-Reviews in Medicinal Chemistry Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design Centenarian Offspring: A Model for Understanding Longevity
Current Vascular Pharmacology CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry Nanomaterials of Natural Bioactive Compounds for Wound Healing: Novel Drug Delivery Approach
Current Drug Delivery Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Recent Developments in Pharmacologic Prophylaxis of Atrial Fibrillation in Patients Undergoing Surgical Revascularization
Cardiovascular & Hematological Agents in Medicinal Chemistry Chemoprotective Mechanism of the Natural Compounds, Epigallocatechin- 3-O-Gallate, Quercetin and Curcumin Against Cancer and Cardiovascular Diseases
Current Medicinal Chemistry Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors
Current Pharmaceutical Design Oxidative Stress Targeting Amyloid Beta Accumulation and Clearance in Alzheimer’s Disease: Insight into Pathological Mechanisms and Therapeutic Strategies
Current Psychopharmacology